nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—epilepsy syndrome	0.218	1	CbGaD
Ketorolac—Nepafenac—Carbamazepine—epilepsy syndrome	0.128	0.308	CrCrCtD
Ketorolac—Nepafenac—Oxcarbazepine—epilepsy syndrome	0.118	0.284	CrCrCtD
Ketorolac—Salsalate—Carbamazepine—epilepsy syndrome	0.0882	0.213	CrCrCtD
Ketorolac—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0813	0.196	CrCrCtD
Ketorolac—PTGS1—Diazepam—epilepsy syndrome	0.0592	0.559	CbGbCtD
Ketorolac—PTGS1—Valproic Acid—epilepsy syndrome	0.0467	0.441	CbGbCtD
Ketorolac—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000437	0.218	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—epilepsy syndrome	0.000234	0.117	CrCbGaD
Ketorolac—Nepafenac—PTGS2—epilepsy syndrome	0.000223	0.111	CrCbGaD
Ketorolac—Fenbufen—PTGS2—epilepsy syndrome	0.000213	0.106	CrCbGaD
Ketorolac—Tolmetin—PTGS2—epilepsy syndrome	0.000185	0.0925	CrCbGaD
Ketorolac—Salsalate—PTGS2—epilepsy syndrome	0.000185	0.0925	CrCbGaD
Ketorolac—Mebendazole—ABCB1—epilepsy syndrome	0.000178	0.0886	CrCbGaD
Ketorolac—Suprofen—PTGS2—epilepsy syndrome	0.000178	0.0886	CrCbGaD
Ketorolac—PTGS2—Spinal Cord Injury—AQP4—epilepsy syndrome	9.78e-05	0.00534	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	9.71e-05	0.0053	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—epilepsy syndrome	9.25e-05	0.00505	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	9.2e-05	0.00502	CbGpPWpGaD
Ketorolac—Ketoprofen—PTGS2—epilepsy syndrome	9.04e-05	0.0451	CrCbGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	8.43e-05	0.0046	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	8.43e-05	0.0046	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PLAT—epilepsy syndrome	8.36e-05	0.00456	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CAT—epilepsy syndrome	8.15e-05	0.00445	CbGpPWpGaD
Ketorolac—Ketoprofen—ALB—epilepsy syndrome	8.05e-05	0.0402	CrCbGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	8.05e-05	0.00439	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—epilepsy syndrome	7.93e-05	0.00432	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—epilepsy syndrome	7.55e-05	0.00412	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL2—epilepsy syndrome	7.5e-05	0.00409	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—GPX1—epilepsy syndrome	7.37e-05	0.00402	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP2C19—epilepsy syndrome	7.24e-05	0.00395	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP11A1—epilepsy syndrome	7.2e-05	0.00393	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	6.82e-05	0.00372	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—epilepsy syndrome	6.8e-05	0.00371	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CCR2—epilepsy syndrome	6.78e-05	0.0037	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.69e-05	0.00365	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.69e-05	0.00365	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP2D6—epilepsy syndrome	6.5e-05	0.00354	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—epilepsy syndrome	6.49e-05	0.00354	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CRP—epilepsy syndrome	6.47e-05	0.00353	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.47e-05	0.00353	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	6.39e-05	0.00349	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—HES1—epilepsy syndrome	6.38e-05	0.00348	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	6.26e-05	0.00341	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	6.26e-05	0.00341	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—NOS1—epilepsy syndrome	6.21e-05	0.00339	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.99e-05	0.00327	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	5.96e-05	0.00325	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	5.89e-05	0.00321	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	5.85e-05	0.00319	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	5.84e-05	0.00319	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	5.63e-05	0.00307	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CCL2—epilepsy syndrome	5.32e-05	0.0029	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	5.31e-05	0.0029	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	5.14e-05	0.0028	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	5.11e-05	0.00279	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.07e-05	0.00277	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	5.06e-05	0.00276	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	5.03e-05	0.00274	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—epilepsy syndrome	4.96e-05	0.00271	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA13—epilepsy syndrome	4.95e-05	0.0027	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	4.88e-05	0.00266	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.68e-05	0.00255	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.64e-05	0.00253	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	4.56e-05	0.00249	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—RELA—epilepsy syndrome	4.47e-05	0.00244	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.47e-05	0.00244	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	4.34e-05	0.00237	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	4.26e-05	0.00232	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	4.23e-05	0.00231	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.06e-05	0.00221	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—epilepsy syndrome	4.04e-05	0.0022	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.99e-05	0.00218	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	3.94e-05	0.00215	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA13—epilepsy syndrome	3.93e-05	0.00215	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	3.91e-05	0.00213	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GLUD1—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CERS1—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADK—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PDXK—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FAR1—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—L2HGDH—epilepsy syndrome	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	3.71e-05	0.00202	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	3.66e-05	0.00199	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDXK—epilepsy syndrome	3.56e-05	0.00194	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.55e-05	0.00193	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	3.44e-05	0.00188	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EPM2A—epilepsy syndrome	3.43e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GAMT—epilepsy syndrome	3.43e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NHLRC1—epilepsy syndrome	3.43e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PNPO—epilepsy syndrome	3.43e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	3.43e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	3.42e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	3.39e-05	0.00185	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	3.34e-05	0.00182	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EPM2A—epilepsy syndrome	3.26e-05	0.00178	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NHLRC1—epilepsy syndrome	3.26e-05	0.00178	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PNPO—epilepsy syndrome	3.26e-05	0.00178	CbGpPWpGaD
Ketorolac—Hypotension—Valproic Acid—epilepsy syndrome	3.24e-05	0.000135	CcSEcCtD
Ketorolac—Asthenia—Carbamazepine—epilepsy syndrome	3.24e-05	0.000135	CcSEcCtD
Ketorolac—Agitation—Gabapentin—epilepsy syndrome	3.24e-05	0.000135	CcSEcCtD
Ketorolac—Diarrhoea—Phenytoin—epilepsy syndrome	3.24e-05	0.000135	CcSEcCtD
Ketorolac—Discomfort—Pregabalin—epilepsy syndrome	3.23e-05	0.000134	CcSEcCtD
Ketorolac—Nausea—Fosphenytoin—epilepsy syndrome	3.23e-05	0.000134	CcSEcCtD
Ketorolac—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.22e-05	0.000134	CcSEcCtD
Ketorolac—Erythema multiforme—Topiramate—epilepsy syndrome	3.22e-05	0.000134	CcSEcCtD
Ketorolac—Angioedema—Gabapentin—epilepsy syndrome	3.22e-05	0.000134	CcSEcCtD
Ketorolac—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.22e-05	0.000134	CcSEcCtD
Ketorolac—Vomiting—Felbamate—epilepsy syndrome	3.21e-05	0.000133	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.21e-05	0.00175	CbGpPWpGaD
Ketorolac—Dry mouth—Pregabalin—epilepsy syndrome	3.2e-05	0.000133	CcSEcCtD
Ketorolac—Pruritus—Carbamazepine—epilepsy syndrome	3.2e-05	0.000133	CcSEcCtD
Ketorolac—PTGS1—Metabolism—QDPR—epilepsy syndrome	3.19e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA4—epilepsy syndrome	3.19e-05	0.00174	CbGpPWpGaD
Ketorolac—Rash—Felbamate—epilepsy syndrome	3.19e-05	0.000132	CcSEcCtD
Ketorolac—Eye disorder—Topiramate—epilepsy syndrome	3.18e-05	0.000132	CcSEcCtD
Ketorolac—Dermatitis—Felbamate—epilepsy syndrome	3.18e-05	0.000132	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—POMC—epilepsy syndrome	3.18e-05	0.00174	CbGpPWpGaD
Ketorolac—Malaise—Gabapentin—epilepsy syndrome	3.18e-05	0.000132	CcSEcCtD
Ketorolac—Tinnitus—Topiramate—epilepsy syndrome	3.18e-05	0.000132	CcSEcCtD
Ketorolac—Vertigo—Gabapentin—epilepsy syndrome	3.17e-05	0.000132	CcSEcCtD
Ketorolac—Headache—Felbamate—epilepsy syndrome	3.17e-05	0.000131	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.17e-05	0.00173	CbGpPWpGaD
Ketorolac—Confusional state—Pregabalin—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Cardiac disorder—Topiramate—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Flushing—Topiramate—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Syncope—Gabapentin—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Leukopenia—Gabapentin—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Ketorolac—Dizziness—Clonazepam—epilepsy syndrome	3.15e-05	0.000131	CcSEcCtD
Ketorolac—Nausea—Vigabatrin—epilepsy syndrome	3.15e-05	0.000131	CcSEcCtD
Ketorolac—Vomiting—Zonisamide—epilepsy syndrome	3.15e-05	0.000131	CcSEcCtD
Ketorolac—Insomnia—Valproic Acid—epilepsy syndrome	3.14e-05	0.00013	CcSEcCtD
Ketorolac—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.14e-05	0.00013	CcSEcCtD
Ketorolac—Oedema—Pregabalin—epilepsy syndrome	3.14e-05	0.00013	CcSEcCtD
Ketorolac—Asthenia—Lamotrigine—epilepsy syndrome	3.13e-05	0.00013	CcSEcCtD
Ketorolac—Dizziness—Phenytoin—epilepsy syndrome	3.13e-05	0.00013	CcSEcCtD
Ketorolac—Rash—Zonisamide—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Ketorolac—Infection—Pregabalin—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Ketorolac—Paraesthesia—Valproic Acid—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Ketorolac—Palpitations—Gabapentin—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Ketorolac—Dermatitis—Zonisamide—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Ketorolac—Dizziness—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000129	CcSEcCtD
Ketorolac—Nausea—Diazepam—epilepsy syndrome	3.1e-05	0.000129	CcSEcCtD
Ketorolac—Loss of consciousness—Gabapentin—epilepsy syndrome	3.1e-05	0.000129	CcSEcCtD
Ketorolac—Headache—Zonisamide—epilepsy syndrome	3.1e-05	0.000129	CcSEcCtD
Ketorolac—Dyspnoea—Valproic Acid—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Diarrhoea—Carbamazepine—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Angiopathy—Topiramate—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Pruritus—Lamotrigine—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Shock—Pregabalin—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Somnolence—Valproic Acid—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Ketorolac—Immune system disorder—Topiramate—epilepsy syndrome	3.08e-05	0.000128	CcSEcCtD
Ketorolac—Nervous system disorder—Pregabalin—epilepsy syndrome	3.08e-05	0.000128	CcSEcCtD
Ketorolac—Cough—Gabapentin—epilepsy syndrome	3.08e-05	0.000128	CcSEcCtD
Ketorolac—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.07e-05	0.000128	CcSEcCtD
Ketorolac—Mediastinal disorder—Topiramate—epilepsy syndrome	3.07e-05	0.000127	CcSEcCtD
Ketorolac—Tachycardia—Pregabalin—epilepsy syndrome	3.06e-05	0.000127	CcSEcCtD
Ketorolac—Chills—Topiramate—epilepsy syndrome	3.06e-05	0.000127	CcSEcCtD
Ketorolac—Dyspepsia—Valproic Acid—epilepsy syndrome	3.06e-05	0.000127	CcSEcCtD
Ketorolac—Convulsion—Gabapentin—epilepsy syndrome	3.06e-05	0.000127	CcSEcCtD
Ketorolac—Skin disorder—Pregabalin—epilepsy syndrome	3.05e-05	0.000127	CcSEcCtD
Ketorolac—Hypertension—Gabapentin—epilepsy syndrome	3.04e-05	0.000126	CcSEcCtD
Ketorolac—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.03e-05	0.000126	CcSEcCtD
Ketorolac—Vomiting—Clonazepam—epilepsy syndrome	3.03e-05	0.000126	CcSEcCtD
Ketorolac—PTGS2—Disease—SV2A—epilepsy syndrome	3.03e-05	0.00165	CbGpPWpGaD
Ketorolac—Decreased appetite—Valproic Acid—epilepsy syndrome	3.02e-05	0.000125	CcSEcCtD
Ketorolac—Alopecia—Topiramate—epilepsy syndrome	3.01e-05	0.000125	CcSEcCtD
Ketorolac—Vomiting—Phenytoin—epilepsy syndrome	3.01e-05	0.000125	CcSEcCtD
Ketorolac—Rash—Clonazepam—epilepsy syndrome	3.01e-05	0.000125	CcSEcCtD
Ketorolac—Dermatitis—Clonazepam—epilepsy syndrome	3e-05	0.000125	CcSEcCtD
Ketorolac—Arthralgia—Gabapentin—epilepsy syndrome	3e-05	0.000125	CcSEcCtD
Ketorolac—Myalgia—Gabapentin—epilepsy syndrome	3e-05	0.000125	CcSEcCtD
Ketorolac—Chest pain—Gabapentin—epilepsy syndrome	3e-05	0.000125	CcSEcCtD
Ketorolac—PTGS1—Metabolism—COX3—epilepsy syndrome	3e-05	0.00164	CbGpPWpGaD
Ketorolac—Nausea—Felbamate—epilepsy syndrome	3e-05	0.000125	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3e-05	0.000124	CcSEcCtD
Ketorolac—Vomiting—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Fatigue—Valproic Acid—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Anxiety—Gabapentin—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Anorexia—Pregabalin—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Dizziness—Carbamazepine—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Diarrhoea—Lamotrigine—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Headache—Clonazepam—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Rash—Phenytoin—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Mental disorder—Topiramate—epilepsy syndrome	2.99e-05	0.000124	CcSEcCtD
Ketorolac—Dermatitis—Phenytoin—epilepsy syndrome	2.98e-05	0.000124	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.98e-05	0.000124	CcSEcCtD
Ketorolac—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PDXK—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CERS1—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FAR1—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADK—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GLUD1—epilepsy syndrome	2.98e-05	0.00163	CbGpPWpGaD
Ketorolac—Rash—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Pain—Valproic Acid—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Constipation—Valproic Acid—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Headache—Phenytoin—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Erythema—Topiramate—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Malnutrition—Topiramate—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Discomfort—Gabapentin—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Ketorolac—Headache—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000122	CcSEcCtD
Ketorolac—Nausea—Zonisamide—epilepsy syndrome	2.94e-05	0.000122	CcSEcCtD
Ketorolac—Dry mouth—Gabapentin—epilepsy syndrome	2.94e-05	0.000122	CcSEcCtD
Ketorolac—Hypotension—Pregabalin—epilepsy syndrome	2.93e-05	0.000122	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.93e-05	0.0016	CbGpPWpGaD
Ketorolac—Flatulence—Topiramate—epilepsy syndrome	2.92e-05	0.000121	CcSEcCtD
Ketorolac—Tension—Topiramate—epilepsy syndrome	2.91e-05	0.000121	CcSEcCtD
Ketorolac—Dysgeusia—Topiramate—epilepsy syndrome	2.91e-05	0.000121	CcSEcCtD
Ketorolac—Confusional state—Gabapentin—epilepsy syndrome	2.9e-05	0.00012	CcSEcCtD
Ketorolac—Dizziness—Lamotrigine—epilepsy syndrome	2.89e-05	0.00012	CcSEcCtD
Ketorolac—Nervousness—Topiramate—epilepsy syndrome	2.88e-05	0.00012	CcSEcCtD
Ketorolac—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.88e-05	0.000119	CcSEcCtD
Ketorolac—Oedema—Gabapentin—epilepsy syndrome	2.88e-05	0.000119	CcSEcCtD
Ketorolac—Vomiting—Carbamazepine—epilepsy syndrome	2.87e-05	0.000119	CcSEcCtD
Ketorolac—Back pain—Topiramate—epilepsy syndrome	2.87e-05	0.000119	CcSEcCtD
Ketorolac—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.86e-05	0.000119	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.86e-05	0.000119	CcSEcCtD
Ketorolac—Infection—Gabapentin—epilepsy syndrome	2.86e-05	0.000119	CcSEcCtD
Ketorolac—Rash—Carbamazepine—epilepsy syndrome	2.85e-05	0.000118	CcSEcCtD
Ketorolac—Dermatitis—Carbamazepine—epilepsy syndrome	2.85e-05	0.000118	CcSEcCtD
Ketorolac—PTGS1—Metabolism—KCNB1—epilepsy syndrome	2.85e-05	0.00155	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	2.85e-05	0.00155	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	2.85e-05	0.00155	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PFKL—epilepsy syndrome	2.85e-05	0.00155	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	2.85e-05	0.00155	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.84e-05	0.000118	CcSEcCtD
Ketorolac—Insomnia—Pregabalin—epilepsy syndrome	2.84e-05	0.000118	CcSEcCtD
Ketorolac—Nausea—Clonazepam—epilepsy syndrome	2.83e-05	0.000118	CcSEcCtD
Ketorolac—Headache—Carbamazepine—epilepsy syndrome	2.83e-05	0.000118	CcSEcCtD
Ketorolac—Shock—Gabapentin—epilepsy syndrome	2.83e-05	0.000118	CcSEcCtD
Ketorolac—Nervous system disorder—Gabapentin—epilepsy syndrome	2.82e-05	0.000117	CcSEcCtD
Ketorolac—Paraesthesia—Pregabalin—epilepsy syndrome	2.82e-05	0.000117	CcSEcCtD
Ketorolac—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.82e-05	0.000117	CcSEcCtD
Ketorolac—Nausea—Phenytoin—epilepsy syndrome	2.81e-05	0.000117	CcSEcCtD
Ketorolac—Tachycardia—Gabapentin—epilepsy syndrome	2.81e-05	0.000117	CcSEcCtD
Ketorolac—Dyspnoea—Pregabalin—epilepsy syndrome	2.8e-05	0.000116	CcSEcCtD
Ketorolac—Nausea—Oxcarbazepine—epilepsy syndrome	2.8e-05	0.000116	CcSEcCtD
Ketorolac—Vision blurred—Topiramate—epilepsy syndrome	2.8e-05	0.000116	CcSEcCtD
Ketorolac—Skin disorder—Gabapentin—epilepsy syndrome	2.8e-05	0.000116	CcSEcCtD
Ketorolac—Somnolence—Pregabalin—epilepsy syndrome	2.79e-05	0.000116	CcSEcCtD
Ketorolac—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.78e-05	0.000115	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.78e-05	0.00152	CbGpPWpGaD
Ketorolac—Tremor—Topiramate—epilepsy syndrome	2.78e-05	0.000115	CcSEcCtD
Ketorolac—Vomiting—Lamotrigine—epilepsy syndrome	2.78e-05	0.000115	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.76e-05	0.00151	CbGpPWpGaD
Ketorolac—Urticaria—Valproic Acid—epilepsy syndrome	2.76e-05	0.000114	CcSEcCtD
Ketorolac—Rash—Lamotrigine—epilepsy syndrome	2.75e-05	0.000114	CcSEcCtD
Ketorolac—Ill-defined disorder—Topiramate—epilepsy syndrome	2.75e-05	0.000114	CcSEcCtD
Ketorolac—Dermatitis—Lamotrigine—epilepsy syndrome	2.75e-05	0.000114	CcSEcCtD
Ketorolac—Abdominal pain—Valproic Acid—epilepsy syndrome	2.74e-05	0.000114	CcSEcCtD
Ketorolac—Body temperature increased—Valproic Acid—epilepsy syndrome	2.74e-05	0.000114	CcSEcCtD
Ketorolac—Anorexia—Gabapentin—epilepsy syndrome	2.74e-05	0.000114	CcSEcCtD
Ketorolac—Anaemia—Topiramate—epilepsy syndrome	2.74e-05	0.000114	CcSEcCtD
Ketorolac—Headache—Lamotrigine—epilepsy syndrome	2.74e-05	0.000114	CcSEcCtD
Ketorolac—Decreased appetite—Pregabalin—epilepsy syndrome	2.73e-05	0.000113	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	2.73e-05	0.00149	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GAMT—epilepsy syndrome	2.73e-05	0.00149	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EPM2A—epilepsy syndrome	2.73e-05	0.00149	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PNPO—epilepsy syndrome	2.73e-05	0.00149	CbGpPWpGaD
Ketorolac—Agitation—Topiramate—epilepsy syndrome	2.73e-05	0.000113	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.71e-05	0.000112	CcSEcCtD
Ketorolac—Fatigue—Pregabalin—epilepsy syndrome	2.71e-05	0.000112	CcSEcCtD
Ketorolac—PTGS2—Disease—PFKL—epilepsy syndrome	2.7e-05	0.00147	CbGpPWpGaD
Ketorolac—Hypotension—Gabapentin—epilepsy syndrome	2.69e-05	0.000112	CcSEcCtD
Ketorolac—Nausea—Carbamazepine—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Ketorolac—Pain—Pregabalin—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Ketorolac—Constipation—Pregabalin—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Ketorolac—Malaise—Topiramate—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Ketorolac—Vertigo—Topiramate—epilepsy syndrome	2.67e-05	0.000111	CcSEcCtD
Ketorolac—Syncope—Topiramate—epilepsy syndrome	2.66e-05	0.00011	CcSEcCtD
Ketorolac—Leukopenia—Topiramate—epilepsy syndrome	2.66e-05	0.00011	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.62e-05	0.000109	CcSEcCtD
Ketorolac—Palpitations—Topiramate—epilepsy syndrome	2.62e-05	0.000109	CcSEcCtD
Ketorolac—Loss of consciousness—Topiramate—epilepsy syndrome	2.61e-05	0.000108	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.6e-05	0.00142	CbGpPWpGaD
Ketorolac—Insomnia—Gabapentin—epilepsy syndrome	2.6e-05	0.000108	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NEU1—epilepsy syndrome	2.6e-05	0.00142	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—UPB1—epilepsy syndrome	2.6e-05	0.00142	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ATIC—epilepsy syndrome	2.6e-05	0.00142	CbGpPWpGaD
Ketorolac—Nausea—Lamotrigine—epilepsy syndrome	2.59e-05	0.000108	CcSEcCtD
Ketorolac—Cough—Topiramate—epilepsy syndrome	2.59e-05	0.000107	CcSEcCtD
Ketorolac—Feeling abnormal—Pregabalin—epilepsy syndrome	2.59e-05	0.000107	CcSEcCtD
Ketorolac—Paraesthesia—Gabapentin—epilepsy syndrome	2.58e-05	0.000107	CcSEcCtD
Ketorolac—Convulsion—Topiramate—epilepsy syndrome	2.57e-05	0.000107	CcSEcCtD
Ketorolac—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.57e-05	0.000107	CcSEcCtD
Ketorolac—Dyspnoea—Gabapentin—epilepsy syndrome	2.57e-05	0.000107	CcSEcCtD
Ketorolac—Hypertension—Topiramate—epilepsy syndrome	2.56e-05	0.000106	CcSEcCtD
Ketorolac—Somnolence—Gabapentin—epilepsy syndrome	2.56e-05	0.000106	CcSEcCtD
Ketorolac—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.56e-05	0.000106	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.53e-05	0.00138	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.53e-05	0.00138	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA4—epilepsy syndrome	2.53e-05	0.00138	CbGpPWpGaD
Ketorolac—Dyspepsia—Gabapentin—epilepsy syndrome	2.53e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.53e-05	0.00138	CbGpPWpGaD
Ketorolac—Chest pain—Topiramate—epilepsy syndrome	2.53e-05	0.000105	CcSEcCtD
Ketorolac—Myalgia—Topiramate—epilepsy syndrome	2.53e-05	0.000105	CcSEcCtD
Ketorolac—Arthralgia—Topiramate—epilepsy syndrome	2.53e-05	0.000105	CcSEcCtD
Ketorolac—Anxiety—Topiramate—epilepsy syndrome	2.52e-05	0.000104	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.51e-05	0.000104	CcSEcCtD
Ketorolac—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	2.51e-05	0.00137	CbGpPWpGaD
Ketorolac—Decreased appetite—Gabapentin—epilepsy syndrome	2.5e-05	0.000104	CcSEcCtD
Ketorolac—Discomfort—Topiramate—epilepsy syndrome	2.5e-05	0.000104	CcSEcCtD
Ketorolac—Urticaria—Pregabalin—epilepsy syndrome	2.49e-05	0.000103	CcSEcCtD
Ketorolac—Asthenia—Valproic Acid—epilepsy syndrome	2.49e-05	0.000103	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Ketorolac—Fatigue—Gabapentin—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Ketorolac—Body temperature increased—Pregabalin—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Ketorolac—Abdominal pain—Pregabalin—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Ketorolac—Dry mouth—Topiramate—epilepsy syndrome	2.47e-05	0.000103	CcSEcCtD
Ketorolac—PTGS2—Disease—STX1B—epilepsy syndrome	2.47e-05	0.00135	CbGpPWpGaD
Ketorolac—Pain—Gabapentin—epilepsy syndrome	2.46e-05	0.000102	CcSEcCtD
Ketorolac—Constipation—Gabapentin—epilepsy syndrome	2.46e-05	0.000102	CcSEcCtD
Ketorolac—Pruritus—Valproic Acid—epilepsy syndrome	2.46e-05	0.000102	CcSEcCtD
Ketorolac—Confusional state—Topiramate—epilepsy syndrome	2.44e-05	0.000101	CcSEcCtD
Ketorolac—Oedema—Topiramate—epilepsy syndrome	2.42e-05	0.000101	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	2.42e-05	0.00132	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GBE1—epilepsy syndrome	2.42e-05	0.00132	CbGpPWpGaD
Ketorolac—Infection—Topiramate—epilepsy syndrome	2.41e-05	9.99e-05	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.39e-05	0.0013	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—COX3—epilepsy syndrome	2.38e-05	0.0013	CbGpPWpGaD
Ketorolac—Shock—Topiramate—epilepsy syndrome	2.38e-05	9.89e-05	CcSEcCtD
Ketorolac—Diarrhoea—Valproic Acid—epilepsy syndrome	2.38e-05	9.86e-05	CcSEcCtD
Ketorolac—Nervous system disorder—Topiramate—epilepsy syndrome	2.37e-05	9.86e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Gabapentin—epilepsy syndrome	2.37e-05	9.84e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Topiramate—epilepsy syndrome	2.37e-05	9.84e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.36e-05	0.00129	CbGpPWpGaD
Ketorolac—Tachycardia—Topiramate—epilepsy syndrome	2.36e-05	9.81e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.35e-05	9.77e-05	CcSEcCtD
Ketorolac—Skin disorder—Topiramate—epilepsy syndrome	2.35e-05	9.76e-05	CcSEcCtD
Ketorolac—Hyperhidrosis—Topiramate—epilepsy syndrome	2.34e-05	9.72e-05	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.33e-05	0.00127	CbGpPWpGaD
Ketorolac—Hypersensitivity—Pregabalin—epilepsy syndrome	2.31e-05	9.6e-05	CcSEcCtD
Ketorolac—Anorexia—Topiramate—epilepsy syndrome	2.31e-05	9.58e-05	CcSEcCtD
Ketorolac—Dizziness—Valproic Acid—epilepsy syndrome	2.3e-05	9.53e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CPSF4—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GBE1—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Ketorolac—Urticaria—Gabapentin—epilepsy syndrome	2.29e-05	9.49e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ASAH1—epilepsy syndrome	2.28e-05	0.00124	CbGpPWpGaD
Ketorolac—Abdominal pain—Gabapentin—epilepsy syndrome	2.27e-05	9.44e-05	CcSEcCtD
Ketorolac—Body temperature increased—Gabapentin—epilepsy syndrome	2.27e-05	9.44e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.27e-05	0.00124	CbGpPWpGaD
Ketorolac—Hypotension—Topiramate—epilepsy syndrome	2.26e-05	9.39e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.26e-05	0.00123	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.26e-05	0.00123	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.26e-05	0.00123	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.26e-05	0.00123	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.26e-05	0.00123	CbGpPWpGaD
Ketorolac—Asthenia—Pregabalin—epilepsy syndrome	2.25e-05	9.35e-05	CcSEcCtD
Ketorolac—Pruritus—Pregabalin—epilepsy syndrome	2.22e-05	9.22e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—STXBP1—epilepsy syndrome	2.21e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.21e-05	0.0012	CbGpPWpGaD
Ketorolac—Vomiting—Valproic Acid—epilepsy syndrome	2.21e-05	9.16e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.21e-05	9.16e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.19e-05	0.0012	CbGpPWpGaD
Ketorolac—Insomnia—Topiramate—epilepsy syndrome	2.19e-05	9.09e-05	CcSEcCtD
Ketorolac—Rash—Valproic Acid—epilepsy syndrome	2.19e-05	9.09e-05	CcSEcCtD
Ketorolac—Dermatitis—Valproic Acid—epilepsy syndrome	2.19e-05	9.08e-05	CcSEcCtD
Ketorolac—Headache—Valproic Acid—epilepsy syndrome	2.17e-05	9.03e-05	CcSEcCtD
Ketorolac—Paraesthesia—Topiramate—epilepsy syndrome	2.17e-05	9.03e-05	CcSEcCtD
Ketorolac—Dyspnoea—Topiramate—epilepsy syndrome	2.16e-05	8.96e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NT5E—epilepsy syndrome	2.16e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALAD—epilepsy syndrome	2.16e-05	0.00118	CbGpPWpGaD
Ketorolac—Somnolence—Topiramate—epilepsy syndrome	2.15e-05	8.94e-05	CcSEcCtD
Ketorolac—Diarrhoea—Pregabalin—epilepsy syndrome	2.15e-05	8.91e-05	CcSEcCtD
Ketorolac—Dyspepsia—Topiramate—epilepsy syndrome	2.13e-05	8.85e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Gabapentin—epilepsy syndrome	2.12e-05	8.8e-05	CcSEcCtD
Ketorolac—Decreased appetite—Topiramate—epilepsy syndrome	2.1e-05	8.74e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.09e-05	8.68e-05	CcSEcCtD
Ketorolac—Fatigue—Topiramate—epilepsy syndrome	2.09e-05	8.67e-05	CcSEcCtD
Ketorolac—Dizziness—Pregabalin—epilepsy syndrome	2.08e-05	8.62e-05	CcSEcCtD
Ketorolac—Constipation—Topiramate—epilepsy syndrome	2.07e-05	8.59e-05	CcSEcCtD
Ketorolac—Pain—Topiramate—epilepsy syndrome	2.07e-05	8.59e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.07e-05	0.00113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.07e-05	0.00113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.07e-05	0.00113	CbGpPWpGaD
Ketorolac—Asthenia—Gabapentin—epilepsy syndrome	2.06e-05	8.57e-05	CcSEcCtD
Ketorolac—Nausea—Valproic Acid—epilepsy syndrome	2.06e-05	8.56e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	2.06e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	2.06e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.05e-05	0.00112	CbGpPWpGaD
Ketorolac—Pruritus—Gabapentin—epilepsy syndrome	2.04e-05	8.45e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	2.01e-05	0.0011	CbGpPWpGaD
Ketorolac—Vomiting—Pregabalin—epilepsy syndrome	2e-05	8.28e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Topiramate—epilepsy syndrome	2e-05	8.28e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	1.99e-05	0.00109	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.98e-05	8.22e-05	CcSEcCtD
Ketorolac—Rash—Pregabalin—epilepsy syndrome	1.98e-05	8.21e-05	CcSEcCtD
Ketorolac—Dermatitis—Pregabalin—epilepsy syndrome	1.98e-05	8.21e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ADSL—epilepsy syndrome	1.97e-05	0.00108	CbGpPWpGaD
Ketorolac—Diarrhoea—Gabapentin—epilepsy syndrome	1.97e-05	8.17e-05	CcSEcCtD
Ketorolac—Headache—Pregabalin—epilepsy syndrome	1.97e-05	8.16e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.95e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GLUL—epilepsy syndrome	1.93e-05	0.00106	CbGpPWpGaD
Ketorolac—Urticaria—Topiramate—epilepsy syndrome	1.92e-05	7.98e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.92e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.92e-05	0.00105	CbGpPWpGaD
Ketorolac—Abdominal pain—Topiramate—epilepsy syndrome	1.91e-05	7.95e-05	CcSEcCtD
Ketorolac—Body temperature increased—Topiramate—epilepsy syndrome	1.91e-05	7.95e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.91e-05	0.00104	CbGpPWpGaD
Ketorolac—Dizziness—Gabapentin—epilepsy syndrome	1.9e-05	7.9e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	1.9e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.88e-05	0.00102	CbGpPWpGaD
Ketorolac—Nausea—Pregabalin—epilepsy syndrome	1.86e-05	7.74e-05	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.84e-05	0.001	CbGpPWpGaD
Ketorolac—Vomiting—Gabapentin—epilepsy syndrome	1.83e-05	7.6e-05	CcSEcCtD
Ketorolac—Rash—Gabapentin—epilepsy syndrome	1.81e-05	7.53e-05	CcSEcCtD
Ketorolac—Dermatitis—Gabapentin—epilepsy syndrome	1.81e-05	7.53e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.81e-05	0.000985	CbGpPWpGaD
Ketorolac—Headache—Gabapentin—epilepsy syndrome	1.8e-05	7.48e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Topiramate—epilepsy syndrome	1.78e-05	7.4e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.78e-05	0.000969	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.76e-05	0.000958	CbGpPWpGaD
Ketorolac—Asthenia—Topiramate—epilepsy syndrome	1.74e-05	7.21e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.72e-05	0.000941	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.72e-05	0.000939	CbGpPWpGaD
Ketorolac—Pruritus—Topiramate—epilepsy syndrome	1.71e-05	7.11e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.71e-05	0.000934	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.71e-05	0.000934	CbGpPWpGaD
Ketorolac—Nausea—Gabapentin—epilepsy syndrome	1.71e-05	7.1e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.67e-05	0.000912	CbGpPWpGaD
Ketorolac—Diarrhoea—Topiramate—epilepsy syndrome	1.66e-05	6.88e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.66e-05	0.000903	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.63e-05	0.000891	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.63e-05	0.000891	CbGpPWpGaD
Ketorolac—Dizziness—Topiramate—epilepsy syndrome	1.6e-05	6.65e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.6e-05	0.000872	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.57e-05	0.000854	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.56e-05	0.000851	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.56e-05	0.000851	CbGpPWpGaD
Ketorolac—Vomiting—Topiramate—epilepsy syndrome	1.54e-05	6.39e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.54e-05	0.000838	CbGpPWpGaD
Ketorolac—Rash—Topiramate—epilepsy syndrome	1.53e-05	6.34e-05	CcSEcCtD
Ketorolac—Dermatitis—Topiramate—epilepsy syndrome	1.53e-05	6.33e-05	CcSEcCtD
Ketorolac—Headache—Topiramate—epilepsy syndrome	1.52e-05	6.3e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.51e-05	0.000822	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.5e-05	0.000818	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.46e-05	0.000796	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.45e-05	0.000792	CbGpPWpGaD
Ketorolac—Nausea—Topiramate—epilepsy syndrome	1.44e-05	5.97e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.42e-05	0.000776	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.41e-05	0.000769	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.39e-05	0.000758	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.37e-05	0.000747	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.31e-05	0.000717	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPIA—epilepsy syndrome	1.29e-05	0.000701	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.27e-05	0.000693	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.25e-05	0.000683	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.24e-05	0.000676	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.24e-05	0.000675	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.24e-05	0.000675	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.23e-05	0.000672	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.22e-05	0.000667	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.15e-05	0.000629	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.13e-05	0.000616	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.11e-05	0.000608	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.11e-05	0.000606	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.06e-05	0.000577	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.05e-05	0.000575	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.01e-05	0.000551	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1e-05	0.000548	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLCB1—epilepsy syndrome	9.94e-06	0.000542	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TH—epilepsy syndrome	9.9e-06	0.00054	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	9.83e-06	0.000536	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	9.77e-06	0.000533	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.75e-06	0.000532	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.7e-06	0.000529	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SLC2A1—epilepsy syndrome	9.52e-06	0.00052	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JUNB—epilepsy syndrome	9.45e-06	0.000516	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS1—epilepsy syndrome	9.39e-06	0.000512	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	9.31e-06	0.000508	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HBEGF—epilepsy syndrome	8.95e-06	0.000489	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.85e-06	0.000483	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	8.82e-06	0.000481	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT3—epilepsy syndrome	8.79e-06	0.00048	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ADAM10—epilepsy syndrome	8.59e-06	0.000468	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	8.4e-06	0.000458	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BCHE—epilepsy syndrome	8.36e-06	0.000456	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.26e-06	0.000451	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAT—epilepsy syndrome	8.15e-06	0.000445	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDC42—epilepsy syndrome	8.02e-06	0.000438	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	7.98e-06	0.000435	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—epilepsy syndrome	7.93e-06	0.000433	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLCB1—epilepsy syndrome	7.89e-06	0.00043	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TH—epilepsy syndrome	7.86e-06	0.000429	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.37e-06	0.000402	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HES1—epilepsy syndrome	7.34e-06	0.000401	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FYN—epilepsy syndrome	7.14e-06	0.00039	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H2AFX—epilepsy syndrome	7.11e-06	0.000388	CbGpPWpGaD
Ketorolac—PTGS2—Disease—YWHAZ—epilepsy syndrome	6.86e-06	0.000374	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CCR5—epilepsy syndrome	6.6e-06	0.00036	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—epilepsy syndrome	6.56e-06	0.000358	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAT—epilepsy syndrome	6.47e-06	0.000353	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AGT—epilepsy syndrome	6.47e-06	0.000353	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—APOE—epilepsy syndrome	6.34e-06	0.000346	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCB1—epilepsy syndrome	6.3e-06	0.000344	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TSC2—epilepsy syndrome	6.14e-06	0.000335	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APOE—epilepsy syndrome	6.01e-06	0.000328	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX1—epilepsy syndrome	5.85e-06	0.000319	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6ST—epilepsy syndrome	5.64e-06	0.000308	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS2—epilepsy syndrome	5.6e-06	0.000305	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—POMC—epilepsy syndrome	5.44e-06	0.000297	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AGT—epilepsy syndrome	5.13e-06	0.00028	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—APOE—epilepsy syndrome	5.03e-06	0.000274	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—epilepsy syndrome	4.96e-06	0.000271	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF2—epilepsy syndrome	4.56e-06	0.000249	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.34e-06	0.000237	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—POMC—epilepsy syndrome	4.32e-06	0.000236	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—epilepsy syndrome	4.15e-06	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—epilepsy syndrome	3.94e-06	0.000215	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SRC—epilepsy syndrome	3.33e-06	0.000182	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.18e-06	0.000119	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—epilepsy syndrome	2.07e-06	0.000113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.73e-06	9.45e-05	CbGpPWpGaD
